# Sebbin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sebbin

- Industry: Medical Devices & Equipment
- Headquarters: France
- Website: www.sebbin.com
- Total disclosed funding: $0.5M
- Latest round: Series A (Jul 7, 2020)
- Investors on record: 2

## About

Sebbin is a French company specializing in the development and manufacturing of innovative medical devices for aesthetic and reconstructive surgery, particularly focusing on silicone implants for various procedures.Founded in 1989, Sebbin is headquartered in France and specializes in medical devices. The company has completed 6 deals, with the most recent being a Series A funding round in July 2020, raising EUR 399,850 from investors including Eurazeo and Ventech. The current CEO is Benoit Durand-Barracand.Sebbin specializes in the development and manufacturing of medical devices, focusing on innovative solutions for aesthetic and reconstructive surgery. Its core product offerings include silicone implants for breast augmentation, reconstructive surgeries, and body contouring, catering to healthcare professionals across Europe and Asia, particularly in France, Germany, and Italy.In 2023, Sebbin generated revenue of EUR 20,152,312.40, with an EBITDA of EUR -1,556,574.60, through direct sales of silicone implants and related surgical products, often bundled with service agreements for ongoing support.Sebbin is focused on expanding its product line and exploring new markets. The funding raised in July 2020 will support these initiatives, which include designing new products targeted for launch in the coming years. Additionally, the company aims to penetrate new geographic regions, continuing its expansion within Europe and into Asia by 2025.

## Funding rounds

- Series A, Jul 7, 2020, $0.5M — Ventech, Eurazeo

## Investors

- Ventech (https://capitalatlas.ai/funds/ventech) — Series A
- Eurazeo (https://capitalatlas.ai/funds/eurazeo) — Series A